首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1671851

非侵入性产前检测 (NIPT) 市场按产品/服务、应用、技术、时间段、最终用户和地区划分

Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, By Application, By Technology, By Period, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球非侵入性产前检测 (NIPT) 市场规模估计为 50.8 亿美元，预计到 2032 年将达到 101.5 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.4%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	50.8亿美元
效能资料	从 2020 年到 2024 年	预测期	2025 至 2032 年
预测期：2025-2032年复合年增长率：	10.40％	2032 年价值预测	101.5亿美元

数字。 2025 年非侵入性产前检测 (NIPT)市场占有率（%）（按地区划分）

全球非侵入性产前检测（NIPT）市场用于筛检母亲血液中的胎儿DNA，以确定胎儿是否有遗传异常的高风险，而无需在怀孕期间或对胎儿进行任何侵入性程序。这些测试分析了母亲血液中循环的胎盘游离DNA（cfDNA）。它可以检测您患上唐氏症、13 三体症、18 三体症、性染色体非整倍体和其他异常等遗传疾病的风险。随着基因组技术的进步，NIPT 已成为产前筛检的先锋技术之一，并因其提供准确的结果并避免与羊膜穿刺术等侵入性检查相关的流产风险而受到全球孕妇的广泛欢迎。

市场动态：

全球非侵入性产前检测 (NIPT) 市场受到多种因素的推动，例如母亲年龄增加、唐氏症婴儿出生率上升、对 NIPT 认识的不断提高以及诊断工具的技术进步。然而，低收入国家获得诊断服务的有限性和对堕胎的道德担忧阻碍了市场的成长。重大商机包括新兴国家尚未开发的市场，以及正在进行的扩大NIPT应用的研究和开发，NIPT可检测基因突变和染色体微缺失/重复。

本研究的主要特点

本报告对全球无创产前检测 (NIPT) 市场进行了详细分析，并提供了预测期 (2025-2032) 的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。

它揭示了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。

全球无创的产前检测 (NIPT) 市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数列出。

研究涉及的主要企业包括 Illumina, Inc.、Natera, Inc.、Roche Diagnostics、Ariosa Diagnostics、Verinata Health, Inc.、Yourgene Health、Centogene NV、Eurofins Scientific、F. Hoffmann-La Roche Ltd.、LabCorp、Quest Diagnostics、BGIomeics, Technologies Toffmann-La Roche Ltd。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球无创产前检测 (NIPT) 市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过分析全球无创产前检测（NIPT）市场所使用的各种策略矩阵来简化决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	US$ 5.08 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.40%	2032 Value Projection:	US$ 10.15 Bn

Global Non-invasive Prenatal Testing (NIPT) Market is used to screen fetal DNA in the mother's bloodstream to check if the fetus is at a high risk of genetic abnormalities without being invasive to the pregnancy or the fetus. These tests analyze cell-free DNA (cfDNA) from the placenta that circulates in the mother's bloodstream. They can check the risk of genetic conditions like Down's syndrome, Trisomy 13, Trisomy 18, sex chromosome aneuploidies, and other abnormalities. With advancements in genomic technologies, NIPT has become one of the pioneering techniques used for prenatal screening and is gaining immense popularity among expectant mothers worldwide as it provides accurate results and avoids risks of miscarriage associated with invasive tests like amniocentesis.

Market Dynamics:

The global Non-invasive Prenatal Testing (NIPT) market is driven by factors such as increasing maternal age, rising incidence of babies born with Down's syndrome, growing awareness about NIPT, and technological advancements in diagnostic tools. However, limited access to diagnostic services in low-income countries and ethical issues related to abortion restrain market growth. Significant opportunities include untapped markets in developing countries and ongoing R&D to expand applications of NIPT to detect genetic mutations and chromosomal microdeletion or duplications.

Key Features of the Study:

This report provides in-depth analysis of the global Non-invasive Prenatal Testing (NIPT) market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Non-invasive Prenatal Testing (NIPT) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Inc., Natera, Inc., Roche Diagnostics, Ariosa Diagnostics, Verinata Health, Inc., Yourgene Health, Centogene N.V., Eurofins Scientific, F. Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, BGI Genomics, MedGenome Labs, Genetic Technologies Limited, and Myriad Genetics, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global Non-invasive Prenatal Testing (NIPT) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Non-invasive Prenatal Testing (NIPT) market

Market Segmentation

By Product & Service Insights (Revenue, USD Bn, 2020 - 2032)
- Product
- Consumables
- Assay Kits and Reagents
- Instruments
- Services
By Application Insights (Revenue, USD Bn, 2020 - 2032)
- Trisomy Detection
- Microdeletion Detection
- Sex Chromosome Aneuploidy Detection
By Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Array Technology
- Rolling Circular Amplification
By Period Insights (Revenue, USD Bn, 2020 - 2032)
- 0-12 Weeks
- 13-24 Weeks
- 25-36 Weeks
By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Diagnostic Laboratories
- Home Care Settings
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Illumina, Inc.
- Natera, Inc.
- Roche Diagnostics
- Ariosa Diagnostics
- Verinata Health, Inc.
- Yourgene Health
- Centogene N.V.
- Eurofins Scientific
- Hoffmann-La Roche Ltd.
- LabCorp
- Quest Diagnostics
- BGI Genomics
- MedGenome Labs
- Genetic Technologies Limited
- Myriad Genetics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service
- Global Non-invasive Prenatal Testing (NIPT) Market, By Application
- Global Non-invasive Prenatal Testing (NIPT) Market, By Technology
- Global Non-invasive Prenatal Testing (NIPT) Market, By Period
- Global Non-invasive Prenatal Testing (NIPT) Market, By End User
- Global Non-invasive Prenatal Testing (NIPT) Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Product
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Consumables
Assay Kits and Reagents
Instruments
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Non-invasive Prenatal Testing (NIPT) Market, By Application, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Trisomy Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Microdeletion Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Sex Chromosome Aneuploidy Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Non-invasive Prenatal Testing (NIPT) Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Array Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rolling Circular Amplification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Non-invasive Prenatal Testing (NIPT) Market, By Period, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
0-12 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
13-24 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
25-36 Weeks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Non-invasive Prenatal Testing (NIPT) Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Non-invasive Prenatal Testing (NIPT) Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Natera, Inc.
Roche Diagnostics
Ariosa Diagnostics
Verinata Health, Inc.
Yourgene Health
Centogene N.V.
Eurofins Scientific
Hoffmann-La Roche Ltd.
LabCorp
Quest Diagnostics
BGI Genomics
MedGenome Labs
Genetic Technologies Limited
Myriad Genetics, Inc.

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

非侵入性产前检测 (NIPT) 市场按产品/服务、应用、技术、时间段、最终用户和地区划分